This is a working overview of thymalfasin, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-06 and is reviewed periodically as new material appears.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
Recommended storage for the dry powder is a freezer near minus twenty degrees Celsius, kept desiccated and away from light. Once dissolved, the peptide is less stable and is usually held at two to eight degrees Celsius for short intervals or frozen for longer storage. Stability studies focus on the acetylated terminus and the disulfide linkage because those features define the intact molecule. Common degradation routes include cysteine oxidation, deamidation of asparagine or glutamine side chains, and slow formation of higher-molecular-weight species.
Identity and purity are usually checked by reverse-phase high-performance liquid chromatography, which separates the intact chain from truncated products, together with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion and amino acid analysis add sequence-level evidence. Release testing also covers water content, residual solvents, and counter-ions, all of which influence measured mass and stability. Related-peptide limits are commonly expressed as a percentage of total peak area, with individual unspecified impurities held below a lower threshold.
The lyophilized peptide is a white to off-white powder that dissolves freely in water and in aqueous buffers near neutral pH. Because the molecule carries a net negative charge under physiological conditions, saline and phosphate solutions are the usual vehicles, while strongly acidic media are avoided. Stock solutions are commonly divided into small aliquots so that repeated freezing and thawing can be limited, since cycling may encourage aggregation. Solubility in organic solvents is poor and those solvents are seldom used as primary diluents.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.
Practical handling focuses on limiting adsorption and contamination. The peptide dissolves readily in water, and dilute solutions tend to adhere to plastic and glass surfaces, so an inert carrier protein or a defined buffer can reduce losses in laboratory work. Workers also record the counter-ion form, since an acetate or trifluoroacetate salt changes the mass balance of the weighed powder. Documentation of lot number, purity value, and storage history supports reproducibility when results from different laboratories are compared.
Lyophilized material is generally held at reduced temperature to slow degradation, and storage at minus twenty degrees Celsius or lower is common practice for long-term retention. Short-term working portions are often kept between two and eight degrees Celsius. Once dissolved, the peptide is less stable than the dry powder, and repeated freeze-thaw cycles are associated with loss of material and with aggregate formation. Vials are usually allowed to reach room temperature before opening so that condensation does not introduce moisture, and solutions are protected from light where practical.
Tanabe Young Investigator Award from the American College of Clinical Pharmacology (2014) Division for Drug Metabolism Early Career Achievement Award by the American Society for Pharmacology and Experimental Therapeutics (ASPET) (2015) The International Society for the Study of Xenobiotics (ISSX) North American New Investigator Award in Honor of James R. Gillette (2017) The Daily Record Leading Women Award (2017) Leon I. Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics (2017) John J. Abel Award in Pharmacology from ASPET (2019)
== Lipid kinases == Lipid kinases phosphorylate lipids in the cell, both on the plasma membrane as well as on the membranes of the organelles. The addition of phosphate groups can change the reactivity and localization of the lipid and can be used in signal transmission.
For example, it was shown that the reaction of oganesson with F2 to form the compound OgF2 would release an energy of 106 kcal/mol of which about 46 kcal/mol come from these interactions. For comparison, the spin–orbit interaction for the similar molecule RnF2 is about 10 kcal/mol out of a formation energy of 49 kcal/mol. The same interaction stabilizes the tetrahedral Td configuration for OgF4, as distinct from the square planar D4h one of XeF4, which RnF4 is also expected to have; this is because OgF4 is expected to have two inert electron pairs (7s and 7p1/2). As such, OgF6 is expected to be unbound, continuing an expected trend in the destabilisation of the +6 oxidation state (RnF6 is likewise expected to be much less stable than XeF6). The Og–F bond will most probably be ionic rather than covalent, rendering the oganesson fluorides non-volatile. OgF2 is predicted to be partially ionic due to oganesson's high electropositivity. Oganesson is predicted to be sufficiently electropositive to form an Og–Cl bond with chlorine. A compound of oganesson and tennessine, OgTs4, has been predicted to be potentially stable chemically.
Ephedrine and pseudoephedrine are also relative, not absolute, contraindications. They are generally avoided or used only cautiously at reduced doses with monitoring because they may raise blood pressure. Pseudoephedrine is less potent than ephedrine, and ephedrine is less potent than amphetamine. Phenelzine generally does not need to be stopped before surgery solely because anesthesia is planned. Modern guidance states that MAOI treatment should not be discontinued without conferring with the prescribing psychiatrist, because depressive relapse risk may outweigh perioperative interaction risk when anesthetic and analgesic agents are chosen carefully. In perioperative care, the main drugs to avoid are those with significant serotonin reuptake inhibition or serotonin-releasing activity, especially serotonergic opioid analgesics such as meperidine (pethidine) and tramadol. Other opioids listed as serotonergic or uncertain-risk include methadone, tapentadol, dextromethorphan, dextropropoxyphene, pentazocine, and levorphanol. Other perioperative agents requiring avoidance or special caution include pancuronium, a muscle relaxant sometimes used with general anesthetics, and methylene blue, which has clinically relevant MAOI activity itself. These are not avoided because they are serotonin reuptake inhibitors. Direct-acting vasopressors such as epinephrine, norepinephrine, and phenylephrine are not absolute contraindications, but lower initial doses and careful titration are advised because their pressor effects may be potentiated.
Sources: en.wikipedia.org
=== Prevalence === Necrotizing fasciitis occurs in about 4 people per million per year in the U.S., and about 1 per 100,000 in Western Europe. About 1,000 cases of necrotizing fasciitis occur per year in the United States, but the rates have been increasing. This could be due to increasing awareness of this condition and increased reporting, or increasing antibiotic resistance. Both sexes are affected equally. It is more common among older people and is rare in children.
Frederick McKinley Jones (May 17, 1893 – February 21, 1961) was an American inventor, entrepreneur, engineer, winner of the National Medal of Technology, and an inductee of the National Inventors Hall of Fame. He innovated mobile refrigeration technology. Jones received 61 patents, including 40 for refrigeration technology, and also revolutionized the cinema industry by creating a superior sound system for projectors at the time. Jones co-founded Thermo King and also served as a sergeant in World War I. Due to his contributions to refrigeration technology, Jones is called the "Father of Refrigerated Transportation", and the "King of Cool".
=== Scams === In the early 2000s, numerous companies advertised açaí products online, with many ads featuring counterfeit testimonials and products. In 2009, açaí scams were ranked No. 1 on the U.S. Federal Trade Commission's "scams and rip-offs" list, so that by 2011 sales of açaí flattened as the fad waned. According to the Washington, D.C.–based Center for Science in the Public Interest thousands of consumers had trouble stopping recurrent charges on their credit cards when they canceled free trials of some açai-based products. In 2003, American celebrity doctor Nicholas Perricone included açaí berries among "superfoods", but such extravagant marketing claims regarding açaí as miracle cures for everything from obesity to attention-deficit disorder were challenged in subsequent studies. The FTC handed down an $80 million judgement in January 2012 against five companies that were marketing açaí berry supplements with fraudulent claims that their products promoted weight loss and prevented colon cancer. One company, Central Coast Nutraceuticals, was ordered to pay a $1.5 million settlement.
Sources: en.wikipedia.org
As mayor, Bukele began a "reordering" ("reordenamiento") to revitalize the city's historic downtown area and combat crime. On the day Bukele took office, he reverted the names of two streets in San Salvador (Calle Mayor Roberto D'Aubuisson and Boulevard Coronel José Arturo Castellanos) to Calle San Antonio Abad and Boulevard Venezuela, respectively. Both names had been changed by Bukele's predecessor, Norman Quijano. Zamora, who had become a member of San Salvador's municipal council, stated that the names were reverted due to flaws in the initial renaming process. He added that another street would be named in honor of Castellanos, who provided fake Salvadoran passports to 40,000 Central European Jews to help them escape the Holocaust. Bukele renamed 89 Avenida Norte in honor of Castellanos in June 2016. In December 2016, Bukele inaugurated the Cuscatlán Market to encourage street vendors to relocate their businesses. Many vendors refused to move, despite the market. Political opponents and investigative journalists accused him of negotiating with gangs to organize its construction, since it was located in gang-controlled territory. In January 2016, Bukele began a "San Salvador 100% Illuminated" campaign to "have a light on every corner of San Salvador" to combat crime in the city. The campaign was completed by May 2016. He also installed video-surveillance cameras in parts of San Salvador that were severely affected by crime. Bukele inaugurated the renovated downtown Gerardo Barrios Plaza in October 2017, and the new downtown Lineal Plaza in April 2018.
Half-Life: Decay is a multiplayer-only expansion pack for Valve's first-person shooter Half-Life. Developed by Gearbox Software and published by Sierra On-Line, Decay was released as part of the PlayStation 2 version of Half-Life in 2001. It is the third expansion pack for Half-Life, and like its predecessors, Decay returns to the setting and timeline of the original story, albeit portraying the story from the viewpoint of a different set of protagonists: two scientists working in the Black Mesa Research Facility. Decay is a cooperative multiplayer game, designed to be played by two people working together to pass through the game's levels. Decay was not a critical success, but was received with some positivity by video game journalists. Many reviewers felt the game was best when played with other players, but that its more puzzle-oriented gameplay somewhat detracted from the overall experience. A number of reviews stated that the game simply felt like little more than an extra add-on for the PlayStation 2 version of Half-Life.
Work has also been done for long-chain fatty acids and found that even-numbered sites, which are thought to be derived from C2 position of the acetyl group, are more enriched in 2H than odd-numbered hydrogen that come from C1 position of the acetyl group. Duan et al. reported a strong KIE during the desaturation from oleic acid to linoleic acid. In summary, the underlying physics of SNIF-NMR enables it to measure isotopomers. Another advantage of NMR measurement over mass spectrometry is that it analyzes samples non-destructively. 2H SNIF-NMR has been well industrialized in source identification and forensics, and has contributed much to biochemical pathway studies. The application of 2H SNIF-NMR to geological records is sporadic and still needs exploring.
P. porrigens was once generally regarded as edible, though bland. As of 2011, it is a suspect in two outbreaks in Japan involving fatal encephalopathy. Most victims had preexisting kidney disorders. The first incident occurred in September and October 2004 across nine prefectures in Japan, documenting the sickening of 59 people and the eventual death of 17. Most of those who died had preexisting liver problems and the average age of those affected was 70. Death occurred between 13 and 29 days after the onset of symptoms, which occurred at most three weeks after consumption of the species. The second incident occurred in 2009, when a 65-year-old man who had been on hemodialysis died from acute encephalopathy after eating P. porrigens. The mechanism of action for the toxicity of P. porrigens has not been definitively established, but several possibilities have been suggested. It has been demonstrated that P. porrigens contains an unusual amino acid, Pleurocybellaziridin, which is toxic to the brain cells of rats in cell culture studies, but it has not yet been possible to definitively determine that this was the cause of the fatal encephalopathies. Other mechanisms have been suggested for P. porrigens's apparent toxicity, including the possibility that the fungus may contain toxic levels of cyanide salts. A proposed mechanism of action for the toxicity of P. porrigens has been proposed by Kawagishi, et al.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
Reconstituted solutions are typically kept refrigerated at two to eight degrees Celsius when used within a short window, or frozen in aliquots for longer periods. Repeated freeze-thaw cycles are avoided because they can reduce recovery of intact peptide.